Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis

Methods in Molecular Biology

Volumn 377, Issue , 2007, Pages 203-221

  MacDonald, Tobey J ^a   Pollack, Ian F ^a   Okada, Hideho ^a   Bhattacharya, Soumyaroop ^a   Lyons Weiler, James ^a  

^a NONE

Author keywords

Astrocytoma; Gene expression; Microarray; Tumor progression

Indexed keywords

TUMOR MARKER;

ADULT; ASTROCYTOMA; BIOLOGICAL MODEL; BRAIN TUMOR; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN CHROMOSOME; METHODOLOGY; REPRODUCIBILITY; REVIEW; STATISTICAL ANALYSIS; TUMOR RECURRENCE;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHROMOSOMES, HUMAN; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, GENETIC; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 34547662416     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1385/1-59745-390-0:203     Document Type: Article

References (49)

1. Kleihues, P. and Cavenee, W. K. (ed.) (2000) Pathology &. Genetics. Tumours of the Nervous System. IARC Lyon, France.
2. Batchelor, T. T., Betensky, R. A., Esposito, J. M., et al. (2004) Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin. Cancer Res. 10, 228-233.
3. Simmons, M. L., Lamborn, K. R. Takaliashi, M., et al. (2001) Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res. 61, 1122-1128.
4. Sung, T., Miller, D. C., Hayes, R. L., Alonso, M., Yee, H., and Newcomb, E. W. (2000) Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Pathol. 10, 249-259.
5. Wessels, P. H., Weber, W. E., Raven, G., Ramaekers, F. C., Hopman, A. H., and Twijnstra, A. (2003) Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol. 2, 395-403.
6. Shapiro, J. R. (2002) Genetic alterations associated with adult diffuse astrocytic tumors. Am. J. Med. Genet. 115, 94-201.
7. Fan, X., Munoz, J., Sanko, S. G., and Castresana, J. S. (2002) PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas. Int. J. Oncol, 21, 667-674.
8. Biernat, W., Tohma, Y., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (1997) Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas. Acta. Neuropathol. (Berl). 94, 303-309.
9. Watanabe, K., Tachibana, O., Sato, K., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 6, 217-224.
10. Kleihues, P and Ohgaki, H. (1999) Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol. 1, 44-51.
11. Hegi, M. E., zur Hausen, A., Rüedi, D., Malin, G., and Kleihues, P. (1997) Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas. Int. J. Cancer 73, 57-63.
12. Hermanson, M., Funa, K., Koopmann, J., et al. (1996) Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res. 56, 164-171.
13. Kraus, J. A., Felsberg, J., Tonn, J. C., Reifenberger, G., and Pietsch, T. (2002) Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood. Neuropathol. Appl. Neurobiol, 28, 325-333.
14. Kliatua, S., Peterson, K. M., Brown, K. M., et al. (2003) Overexpression of the EGFR/FKBIP/HIF-2a patahway identified in chilhood astrocytomas by angiogenesis gene profiling. Cancer Res. 63, 1865-1870.
15. Bredel, M., Pollack, I. F., Hamilton, R. L., and James, C. D. (1999) Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood. Clin. Cancer Res. 5, 1786-1792.
16. Pollack, I. F., Finkelstein, S. D., Woods, J., et al. (2002) Expression of p53 and prognosis in children with malignant gliomas. N. Engl. J. Med. 346, 420-427.
17. Golub, T. R., Slonim, D. K., Tamayo, P., et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537.
18. Perou, C. M., Sortie, T., Eisen, M. B., et al. (2000) Molecular portraits of human breast tumours. Nature 406, 747-752.
19. Bittner, M., Meltzer, P., Chen, Y., et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540.
20. Alon, U., Barkai, N., Notterman, D. A., et al. (1999) Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci USA 96, 6745-6750.
21. Alizadeh, A., Eisen, M., Davis, R. E., et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511.
22. van den Boom, J., Wolter, M., Kuik, R., et al. (2003) Characterization of gene expression profiles associated with astrocytoma progression using ologinucleotidebased microarray analysis and real-time reverse transcription-polymerase chain reaction. Am. J. Path. 163, 1033-1043.
23. Godard, S., Gatz, G., Delorenzi, M., et al. (2003) Classification of human astrocytic astrocytomas on the basis of gene expression: A correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res. 63, 6613-6625.
24. Lyons-Weiler, J., Patel, S., Becich, M. J., and Godfrey, T. E. (2004) Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. BMC Bioinformatics 12, 110.
25. Bhattacharya, S., Long, D., and Lyons-Weiler, J. (2003) Overcoming confounded controls in the analysis of gene expression data from microarray experiments. Appl. Bioinformatics 2, 197-208.
26. Lyons-Weiler, J., Patel, S., and Bhattacharya, S. A. (2003) Classification-based machine learning approach for the analysis of genome-wide expression data. Genome Res. 13, 503-512.
27. Pan, W. (2002) A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics 18, 546-554.
28. Tusher, V. G., Tibshirani, R., and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci USA 98, 5116-5121.
29. Shannon, W., Culverhouse, R., and Duncan, J. (2003) Analyzing microarray data using cluster analysis. Pharmacogenomics 4, 41-52.
30. Hastie, T., Tibshirani, R., Eisen, M. B., et al. (2000) 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol. 1, RESEARCH0003.
31. Swiercz, R., Person, M. D., and Bedford, M. T. (2005) Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3). Biochem. J. 386, 85-91.
32. Kowalczyk, P., Woszczynski, M., and Ostrowski, J. (2002) Increased expression of ribosomal protein S2 in liver tumors, posthepactomized livers, and proliferating hepatocytes in vitro. Acta. Biochim. Pol, 49, 615-624.
33. Lyden, D., Young, A. Z., Zagzag, D., et al. (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670-677.
34. Vandeputte, D. A., Troost, D., Leenstra, S., et al. (2002) Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia 38, 329-338.
35. Deed, R. W., Jasiok, M., and Norton, J. D. (1998) Lymphoid-specific expression of the Id3 gene in hematopoietic cells. Selective antagonism of E2A basic helix-loop-helix protein associated with Id3-induced differentiation of erythroleukemia cells. J. Biol. Chem. 273, 8278-8286.
36. Lopez-Carballo, G., Moreno, L., Masia, S., Perez, P., and Barettino, D. (2002) Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-S Y5Y human neuroblastoma cells. J. Biol. Chem. 277, 25, 297-25, 304.
37. Arnold, J. M., Mok, S. C., Purdie, D., and Chenevix-Trench, G. (2001) Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas. Br. J. Cancer 84, 352-359.
38. Gray, C. W., Ward, R. V., Karran, E., et al. (2000) Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem. 267, 5699-5710.
39. Shridhar, V., Sen, A., Chien, J., et al. (2002) Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res. 62, 262-270.
40. Baldi, A., De Luca, A., Morini, M., et al. (2002) The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells. Oncogene 21, 6684-6688.
41. Baldi, A., Battista, T., De Luca, A., et al. (2003) Identification of genes downregulated during melanoma progression: a cDNA array study. Exp. Dermatol. 12, 213-218.
42. Tatenhorst, L., Senner, V., Puttmann, S., and Paulus, W. (2004) Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. ./. Neuropathol. Exp. Neurol. 63, 210-222.
43. Nakada, M., Miyamori, H., Yamashita, J., and Sato, H. (2003) Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Cancer Res. 63, 3364-3369.
44. Scherzer, C. R., Offe, K., Gearing, M., et al. (2004) Loss of apolipoprotein E receptor LRU in Alzheimer disease. Arch. Neurol. 61, 1200-1205.
45. Gliemann, J., Hermey, G., Nykjaer, A., Petersen, C. M., Jacobsen, C., and Andreasen, P. A. (2004) The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand. Biochem. J. 381, 203-212.
46. Gutmann, D. H., James, C. D., Poyhonen, M., et al. (2003) Molecular analysis of astrocytomas presenting after age 10 in individuals with NFl. Neurology 61, 1397-1400.
47. Hunter, S., Young, A., Olson, J., et al. (2002) Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms. J. Neuropathol. Exp. Neurol. 61, 275-281.
48. Lopez-Boado, Y. S., Tolivia, J., and Lopez-Otin, C. (1994) Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. J. Biol, Chem. 269, 26, 871-26, 878.
49. Sugimoto, K., Simard, J., Haagensen, D. E., and Labrie, F. (1994) Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells. J. Steroid Biochem. Mol. Biol. 51, 167-174.